BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3893382)

  • 1. Pancreatic polypeptide in cystic fibrosis.
    Nousia-Arvanitakis S; Tomita T; Desai N; Kimmel JR
    Arch Pathol Lab Med; 1985 Aug; 109(8):722-6. PubMed ID: 3893382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K; Weren M; Proesmans M; Kerem E
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of the pancreas in cystic fibrosis.
    Durie PR
    Neth J Med; 1992 Oct; 41(3-4):97-100. PubMed ID: 1470291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relation between gene mutations and pancreatic exocrine function in patients with cystic fibrosis].
    Radivojević D; Guć-Sćekić M; Djurisić M; Lalić T; Minić P; Kanavakis E
    Srp Arh Celok Lek; 2001; 129 Suppl 1():6-9. PubMed ID: 15637983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype.
    Augarten A; Ben Tov A; Madgar I; Barak A; Akons H; Laufer J; Efrati O; Aviram M; Bentur L; Blau H; Paret G; Wilschanski M; Kerem BS; Yahav Y
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):164-8. PubMed ID: 18301294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The changing face of the exocrine pancreas in cystic fibrosis: pancreatic sufficiency, pancreatitis and genotype.
    Walkowiak J; Lisowska A; Blaszczyński M
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):157-60. PubMed ID: 18301292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet tissue in the heterotopic pancreas.
    Tomita T; Kanabe S
    Arch Pathol Lab Med; 1983 Sep; 107(9):469-72. PubMed ID: 6349578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exocrine pancreatic function in cystic fibrosis.
    Guy-Crotte O; Carrère J; Figarella C
    Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):755-9. PubMed ID: 8864671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway.
    Dorlöchter L; Aksnes L; Fluge G
    Eur J Nutr; 2002 Aug; 41(4):148-52. PubMed ID: 12242582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of tests of exocrine and endocrine pancreatic function in older patients with cystic fibrosis.
    Lamers CB; Jansen JB; Hafkenscheid JC; Jongerius CM
    Pancreas; 1990; 5(1):65-9. PubMed ID: 1688391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma immunoreactive pancreatic cationic trypsinogen in cystic fibrosis: a sensitive indicator of exocrine pancreatic dysfunction.
    Durie PR; Largman C; Brodrick JW; Johnson JH; Gaskin KJ; Forstner GG; Geokas MC
    Pediatr Res; 1981 Oct; 15(10):1351-5. PubMed ID: 7301457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal abnormalities of the pancreas and gut in cystic fibrosis.
    Adrian TE; McKiernan J; Johnstone DI; Hiller EJ; Vyas H; Sarson DL; Bloom SR
    Gastroenterology; 1980 Sep; 79(3):460-5. PubMed ID: 7000612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum immunoreactive pancreatic lipase and cationic trypsinogen for the assessment of exocrine pancreatic function in older patients with cystic fibrosis.
    Cleghorn G; Benjamin L; Corey M; Forstner G; Dati F; Durie P
    Pediatrics; 1986 Mar; 77(3):301-6. PubMed ID: 3951910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Origins of chloride and bicarbonate secretory defects in the cystic fibrosis pancreas, as suggested by pancreatic function studies on control and CF subjects with preserved pancreatic function.
    Kopelman H; Forstner G; Durie P; Corey M
    Clin Invest Med; 1989 Jun; 12(3):207-11. PubMed ID: 2743639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tubeless tests of exocrine pancreatic function in patients with cystic fibrosis.
    Lamers CB
    Neth J Med; 1992 Oct; 41(3-4):101-4. PubMed ID: 1470277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resting energy expenditure in cystic fibrosis as an indicator of disease severity.
    Moudiou T; Galli-Tsinopoulou A; Vamvakoudis E; Nousia-Arvanitakis S
    J Cyst Fibros; 2007 Apr; 6(2):131-6. PubMed ID: 16844432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of exocrine pancreatic function on resting energy expenditure in cystic fibrosis.
    Moudiou T; Galli-Tsinopoulou A; Nousia-Arvanitakis S
    Acta Paediatr; 2007 Oct; 96(10):1521-5. PubMed ID: 17880419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative assessment of pancreatic function by magnetic resonance in cystic fibrosis.
    Heijerman HG; Tjon a Tham RT; Bakker W; Falke TH; Lamers CB
    Neth J Med; 1993 Aug; 43(1-2):59-63. PubMed ID: 8232695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency.
    Durie PR; Forstner GG; Gaskin KJ; Moore DJ; Cleghorn GJ; Wong SS; Corey ML
    Pediatr Res; 1986 Mar; 20(3):209-13. PubMed ID: 3703609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islets of Langerhans in adolescents and adults with cystic fibrosis. A quantitative study.
    Abdul-Karim FW; Dahms BB; Velasco ME; Rodman HM
    Arch Pathol Lab Med; 1986 Jul; 110(7):602-6. PubMed ID: 2872872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.